Botox is not inherently bad for you when used at standard cosmetic doses by a licensed provider. In an FDA review of over 1,400 adverse event reports, cosmetic cases had zero deaths and a rate of serious complications 33 times lower than therapeutic (medical) cases. That said, it’s a potent neurotoxin with real risks that scale with dose, provider skill, and product authenticity.
How Botox Works in Your Body
Botox is a purified form of botulinum toxin, one of the most potent biological substances known. When injected into a muscle, it gets absorbed into the nerve endings that control that muscle. Once inside, it disables the machinery nerve cells use to release their chemical signals. Without those signals, the muscle can’t contract. That’s what smooths wrinkles: the muscle underneath simply stops pulling on the skin.
The effect isn’t permanent. Your nerves gradually sprout new connections and restore communication with the muscle, which is why results typically wear off in three to four months. However, research in animal models shows that even after function appears to return to normal, the underlying nerve signaling can remain subtly depressed for weeks beyond that point. In practical terms, this means recovery is real but not instant at a cellular level.
Cosmetic vs. Medical Doses: A Big Safety Gap
Context matters enormously when evaluating Botox risks. Cosmetic treatments use small doses injected into facial muscles. Medical treatments for conditions like cervical dystonia, overactive bladder, or chronic migraine use significantly higher doses injected into larger or deeper muscles. The safety profiles of these two categories are dramatically different.
When the FDA reviewed 1,437 adverse event reports, 406 came from therapeutic use and 1,031 from cosmetic use. Among therapeutic patients, 217 of those reports were classified as serious, including all 28 reported deaths. Among cosmetic patients, only 36 reports were serious, and none involved a death. The higher complication rate in medical use likely reflects larger doses, more injection sites, and the fact that these patients often have serious underlying health conditions.
For someone getting a standard forehead or crow’s feet treatment, the most common side effects are temporary: bruising at the injection site, mild headache, or a brief drooping of the eyelid if the toxin migrates slightly from where it was placed.
The FDA’s Black Box Warning
Botox carries the FDA’s most serious warning label, which can sound alarming. The warning states that the toxin can spread beyond the injection site and cause symptoms resembling actual botulism: generalized muscle weakness, double vision, drooping eyelids, difficulty swallowing, trouble speaking, and breathing difficulties. These symptoms have been reported hours to weeks after injection.
This warning applies to all botulinum toxin products across all uses. The risk is highest in children being treated for spasticity and in adults receiving high therapeutic doses. For cosmetic patients receiving small doses in facial muscles, systemic spread is extremely rare. Still, the warning exists because when it does happen, swallowing and breathing problems can be life-threatening.
What Happens With Long-Term Use
One concern people have about repeated treatments is whether Botox permanently changes your muscles. The answer is that muscle thinning does occur with repeated injections, but current evidence shows it’s both temporary and reversible once you stop treatment. This is actually considered a benefit in some medical contexts, like reducing the size of an overactive jaw muscle.
On the cosmetic side, long-term users sometimes notice that they need treatments less frequently over time. Their muscles may become trained to contract less forcefully, or mild atrophy reduces the muscle’s ability to create deep wrinkles. Some clinicians view this as a positive outcome rather than a complication. Documented cases of unwanted atrophy do exist, including an “hourglass deformity” in the forehead from migraine injections and thinning of multiple facial muscles from treatments for involuntary facial spasms. These cases are uncommon and are more closely associated with higher doses or frequent injection schedules.
Your Body Can Build Resistance
Over time, some people develop antibodies that neutralize the toxin before it can work. Pooled data from clinical studies puts the overall rate of neutralizing antibody formation at roughly 10%. This doesn’t always mean your treatments stop working, but it can. In one study, 25% of patients developed measurable immunoresistance after a median of about four months from their first injection.
The longer you use Botox, the more likely this becomes. One analysis found antibody prevalence climbed from 12.5% in short-term users to 34.6% in long-term users. If you notice your results fading faster or lasting for shorter periods, antibody formation is one possible explanation. Switching to a different botulinum toxin formulation sometimes helps, though the evidence on that approach is mixed.
The Counterfeit Problem
One of the most significant real-world risks has nothing to do with Botox itself. In early 2024, the CDC and FDA investigated 22 people across 11 states who became ill after receiving botulinum toxin injections from unlicensed providers or in nonmedical settings like homes and spas. All were women aged 25 to 59, and most received cosmetic injections. Over half were hospitalized. Symptoms included drooping eyelids, blurred vision, dry mouth, slurred speech, shortness of breath, and generalized weakness, beginning a median of three days after injection.
The products used were either counterfeit or improperly handled. Counterfeit botulinum toxin may contain unknown concentrations of the active ingredient, meaning the actual dose a person receives is unpredictable. None of the 22 patients died, but six required botulism antitoxin treatment and two were monitored in intensive care. Getting Botox from a board-certified dermatologist or plastic surgeon who sources directly from the manufacturer eliminates this risk almost entirely.
Who Should Avoid Botox
Botox is contraindicated if you have certain neuromuscular conditions like myasthenia gravis or Lambert-Eaton syndrome, because the toxin’s muscle-weakening effect compounds an already compromised system. People with a known allergy to any botulinum toxin product should also avoid it.
The FDA classifies botulinum toxin as a category C drug in pregnancy, meaning animal studies have shown potential harm but no adequate human studies exist. Because of that uncertainty, the standard recommendation is to avoid Botox during pregnancy and breastfeeding. While the toxin is unlikely to reach breast milk, the data simply isn’t strong enough to rule out risk in a situation where treatment is purely elective.
Putting the Risk in Perspective
Botox has been used cosmetically for over two decades, with millions of treatments performed each year. For a healthy adult receiving standard cosmetic doses from a qualified provider using an authentic product, the safety record is strong. The serious risks, including systemic toxin spread, are concentrated in higher-dose medical applications and in patients with pre-existing conditions that make them vulnerable.
The practical risks for most cosmetic users come down to provider selection and product authenticity. A skilled injector minimizes complications like eyelid drooping or uneven results. A legitimate medical setting ensures the product is real, properly stored, and dosed correctly. The toxin itself does what it’s designed to do: temporarily paralyze a small area of muscle. Whether that’s “bad for you” depends largely on the circumstances surrounding how, where, and by whom it’s administered.